Search Results 361-370 of 18461 for autoimmune hepatitis

1. Lipid Droplet Biology and Fatty Liver - Membrane Trafficking in Disease - Mayo Clinic Research

   ... liver disease and hepatic steatosis ... Fatty liver disease ... Over 40% of Americans have a fatty liver that can lead to liver fibrosis, inflammation (hepatitis), ...

2. A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis - Mayo Clinic

   Autoimmune hepatitis; Hepatitis B virus (unless seroconverted and no positive Hepatitis B Virus DNA); Hepatitis C virus and overlap syndrome. Known Gilbert's ...

3. Autoimmune encephalitis - Care at Mayo Clinic

   ... autoimmune neurologists, help diagnose and treat autoimmune encephalitis. Autoimmune encephalitis specialists provide a comprehensive set of diagnostic ...

4. Researchers Test Bioartificial Liver Device to Treat Acute Liver Failure - Mayo Clinic News Network

   ... hepatitis, non-alcoholic fatty liver disease, and liver cancer. Mayo Clinic, which performs approximately 120 liver transplants each year at its hospitals ...

5. Emtricitabine and tenofovir (oral route) - Mayo Clinic

   Liver disease (eg, hepatitis B infection), history of or; Osteomalacia (soft ... Autoimmune disorders (including Graves disease, polymyositis, and ...

6. Research Projects - Artificial Liver and Liver Transplantation: Scott L. Nyberg - Mayo Clinic Research

   Hepatitis, cirrhosis, liver cancer, including ... Hereditary tyrosinemia type 1 is a liver disease caused by a deficiency in the enzyme fumarylacetoacetate ...

7. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

   End stage liver disease secondary to autoimmune etiology (autoimmune hepatitis, primary biliary cirrhosis, or primary sclerosing cholangitis). History of ...

8. A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients with Symptomatic Polycystic Liver Disease - Mayo Clinic

   ... Liver Disease. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

9. End-stage renal disease - Doctors and departments - Mayo Clinic

   Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what underlies autosomal dominant polycystic kidney disease and ...

10. Alina M. Allen, M.D., M.S. - Mayo Clinic Faculty Profiles

    The research program of Alina M. Allen, M.D., at Mayo Clinic is focused on improving outcomes for patients with nonalcoholic fatty liver disease (NAFLD).